LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 30.64 | 17.25 | 1054 | 1887 | 0.5584 | 0.8352 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 30.64 | 17.25 | 3 | 1887 | 0.0016 | -0.2276 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 30.64 | 17.25 | 1227 | 1887 | 0.6501 | 0.8768 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.61 | 17.25 | 616 | 2136 | 0.2883 | 0.6724 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.61 | 17.25 | 1056 | 2136 | 0.4943 | 0.8072 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.61 | 17.25 | 2 | 2136 | 0.0009 | -0.2665 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.61 | 17.25 | 1233 | 2136 | 0.5772 | 0.8480 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.57 | 17.25 | 807 | 2523 | 0.3198 | 0.7069 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.57 | 17.25 | 1057 | 2523 | 0.4189 | 0.7721 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.57 | 17.25 | 2 | 2523 | 0.0008 | -0.2589 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.57 | 17.25 | 1245 | 2523 | 0.4934 | 0.8129 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.54 | 17.25 | 930 | 2679 | 0.3470 | 0.7294 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.54 | 17.25 | 1051 | 2679 | 0.3922 | 0.7587 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.54 | 17.25 | 2 | 2679 | 0.0007 | -0.2562 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.54 | 17.25 | 1247 | 2679 | 0.4653 | 0.8005 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.51 | 17.25 | 955 | 2906 | 0.3286 | 0.7206 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.51 | 17.25 | 1067 | 2906 | 0.3672 | 0.7466 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.51 | 17.25 | 2 | 2906 | 0.0007 | -0.2527 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.51 | 17.25 | 1228 | 2906 | 0.4226 | 0.7801 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.48 | 17.25 | 967 | 3125 | 0.3094 | 0.7104 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.48 | 17.25 | 1081 | 3125 | 0.3458 | 0.7360 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.48 | 17.25 | 1 | 3125 | 0.0003 | -0.3159 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.48 | 17.25 | 1263 | 3125 | 0.4041 | 0.7724 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 42.45 | 17.25 | 959 | 3504 | 0.2737 | 0.6890 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 42.45 | 17.25 | 1072 | 3504 | 0.3059 | 0.7137 | MN20160310_N02 | F07 |